These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

812 related items for PubMed ID: 18502492

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity.
    Limsuwan T, Castells MC.
    Expert Opin Drug Saf; 2010 Jan; 9(1):39-53. PubMed ID: 20001753
    [Abstract] [Full Text] [Related]

  • 3. Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses.
    Lee CW, Matulonis UA, Castells MC.
    Gynecol Oncol; 2005 Nov; 99(2):393-9. PubMed ID: 16054201
    [Abstract] [Full Text] [Related]

  • 4. Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions.
    Lee CW, Matulonis UA, Castells MC.
    Gynecol Oncol; 2004 Nov; 95(2):370-6. PubMed ID: 15491759
    [Abstract] [Full Text] [Related]

  • 5. Rapid desensitization for hypersensitivity reactions to chemotherapy agents.
    Castells M.
    Curr Opin Allergy Clin Immunol; 2006 Aug; 6(4):271-7. PubMed ID: 16825867
    [Abstract] [Full Text] [Related]

  • 6. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment.
    Madrigal-Burgaleta R, Berges-Gimeno MP, Angel-Pereira D, Ferreiro-Monteagudo R, Guillen-Ponce C, Pueyo C, Gomez de Salazar E, Alvarez-Cuesta E.
    Allergy; 2013 Jul; 68(7):853-61. PubMed ID: 23647576
    [Abstract] [Full Text] [Related]

  • 7. Acetylsalicylic acid and montelukast block mast cell mediator-related symptoms during rapid desensitization.
    Breslow RG, Caiado J, Castells MC.
    Ann Allergy Asthma Immunol; 2009 Feb; 102(2):155-60. PubMed ID: 19230468
    [Abstract] [Full Text] [Related]

  • 8. Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin.
    Li Q, Cohn D, Waller A, Backes F, Copeland L, Fowler J, Salani R, O'Malley D.
    Gynecol Oncol; 2014 Oct; 135(1):90-4. PubMed ID: 25110329
    [Abstract] [Full Text] [Related]

  • 9. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment.
    Brennan PJ, Rodriguez Bouza T, Hsu FI, Sloane DE, Castells MC.
    J Allergy Clin Immunol; 2009 Dec; 124(6):1259-66. PubMed ID: 19910036
    [Abstract] [Full Text] [Related]

  • 10. Carboplatin desensitization.
    Choi J, Harnett P, Fulcher DA.
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):137-41. PubMed ID: 15328672
    [Abstract] [Full Text] [Related]

  • 11. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments.
    Feldweg AM, Lee CW, Matulonis UA, Castells M.
    Gynecol Oncol; 2005 Mar; 96(3):824-9. PubMed ID: 15721432
    [Abstract] [Full Text] [Related]

  • 12. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.
    Hesterberg PE, Banerji A, Oren E, Penson RT, Krasner CN, Seiden MV, Wong JT.
    J Allergy Clin Immunol; 2009 Jun; 123(6):1262-7.e1. PubMed ID: 19501233
    [Abstract] [Full Text] [Related]

  • 13. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
    Wong JT, Ling M, Patil S, Banerji A, Long A.
    J Allergy Clin Immunol Pract; 2014 Jun; 2(1):40-5. PubMed ID: 24565767
    [Abstract] [Full Text] [Related]

  • 14. Clopidogrel hypersensitivity: a novel multi-day outpatient oral desensitization regimen.
    Fajt M, Petrov A.
    Ann Pharmacother; 2010 Jan; 44(1):11-8. PubMed ID: 20009004
    [Abstract] [Full Text] [Related]

  • 15. Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies.
    Robinson JB, Singh D, Bodurka-Bevers DC, Wharton JT, Gershenson DM, Wolf JK.
    Gynecol Oncol; 2001 Sep; 82(3):550-8. PubMed ID: 11520154
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy.
    Wang AL, Patil SU, Long AA, Banerji A.
    Ann Allergy Asthma Immunol; 2015 Nov; 115(5):422-8. PubMed ID: 26298407
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol.
    Gammon D, Bhargava P, McCormick MJ.
    Oncologist; 2004 Nov; 9(5):546-9. PubMed ID: 15477639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.